Asian Paints

2579.9 11.30

Cipla

1553.4 -24.40

Eicher Motors

6580.5 155.50

Nestle India

1208.5 -4.10

Grasim Inds

2804 -5.80

Hero Motocorp

5363 12.00

Hindalco Inds.

743.8 4.75

Hind. Unilever

2633.4 -33.20

ITC

407.35 -8.55

Trent

5528.5 -0.50

Larsen & Toubro

3553.6 -39.00

M & M

3561.3 79.80

Reliance Industr

1375 15.70

Tata Consumer

1072.4 1.30

Tata Motors

691.7 4.20

Tata Steel

167.68 0.87

Wipro

243.67 -1.30

Apollo Hospitals

7804.5 -95.50

Dr Reddy's Labs

1268.1 15.10

Titan Company

3665.3 -25.80

SBI

806.6 -2.80

Shriram Finance

592.5 6.70

Bharat Electron

370.8 -1.70

Kotak Mah. Bank

1945.5 -4.20

Infosys

1444.6 -18.40

Bajaj Finance

937.6 2.85

Adani Enterp.

2281.4 2.60

Sun Pharma.Inds.

1593.6 11.30

JSW Steel

1073.1 0.70

HDFC Bank

963.4 2.15

TCS

3048.3 -47.40

ICICI Bank

1402.8 -2.70

Power Grid Corpn

285.35 3.55

Maruti Suzuki

14895 233.00

IndusInd Bank

757.05 2.20

Axis Bank

1055.9 5.50

HCL Technologies

1419 -24.30

O N G C

234.13 -1.59

NTPC

328.7 -1.35

Coal India

392.65 1.20

Bharti Airtel

1895.3 14.90

Tech Mahindra

1477.9 -22.50

Adani Ports

1321.8 -6.40

HDFC Life Insur.

759.55 5.30

SBI Life Insuran

1805.3 14.20

UltraTech Cem.

12601 -50.00

Bajaj Auto

9084.5 13.50

Bajaj Finserv

2014.4 12.20

Eternal Ltd

329.15 2.90

Mid-Session - Detailed News Back
Sensex, Nifty trade lower; FMCG shares rally for 3rd day
02-Sep-25   14:40 Hrs IST
The key equity benchmarks pared all gains and traded with moderate losses in mid-afternoon trade, despite robust GST collection in August. Investors are closely monitoring developments on U.S. tariff measures, FII outcome and monthly auto sales data. The Nifty slipped below 24,550 mark.

FMCG shares witnessed buying demand for third consecutive trading session.

At 14:25 IST, the barometer index, the S&P BSE Sensex declined 271.49 points or 0.33% to 80,092.15. The Nifty 50 index fell 79.10 points or 0.33% to 24,540.60.

The broader market outperformed the headline indices. The S&P BSE Mid-Cap index rose 0.22% and the S&P BSE Small-Cap index advanced 0.52%.

The market breadth was strong. On the BSE, 2,421 shares rose and 1,659 shares fell. A total of 151 shares were unchanged.

Economy:

India collected 1.86 trillion rupees ($21.26 billion) as goods and services tax in August, 6.5% higher than the same period last year, the government said on Monday.

Trump Tariffs:

Activity on the domestic bourses will be in focus after U.S. President Donald Trump reportedly said that India had offered to reduce its tariffs on U.S. imports to zero.

They have now offered to cut their Tariffs to nothing, but it's getting late. They should have done so years ago,' U.S. President Donald Trump wrote on Truth Social. He added that the U.S.′ relationship with India was 'one sided', the report added.

Buzzing Index:

The Nifty FMCG Index gained 0.80% to 56,625.60. The index jumped 1.82% for the third consecutive trading sessions.

Dabur India (up 3.49%), United Breweries (up 2.57%), Emami (up 2.38%), Nestle India (up 1.85%) and Colgate-Palmolive (India) (up 1.69%), Godrej Consumer Products (up 1.45%), Marico (up 1.33%), Hindustan Unilever (up 1.27%), Tata Consumer Products (up 1.12%) and Radico Khaitan (up 0.91%) advanced.

Numbers to Track:

The yield on India's 10-year benchmark federal paper shed 0.03% to 6.583 from the previous close of 6.585.

In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 88.1325 compared with its close of 88.1000 during the previous trading session.

MCX Gold futures for 3 October 2025 settlement rose 0.08% to Rs 104,848.

The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.56% to 98.23.

The United States 10-year bond yield rose 0.71% to 4.276.

In the commodities market, Brent crude for November 2025 settlement jumped $1.59 or 2.36% to $69.07 a barrel.

Stocks in Spotlight:

Glenmark Pharmaceuticals shed 0.40%. The company announced that its U.S.-based subsidiary, Glenmark Pharmaceuticals Inc., USA, will launch Eribulin Mesylate injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials, in the U.S. market this September.

Powered by Capital Market - Live News


DJIA 45424.68
-217.62 -0.48%
S&P 500 6502.38
-20.70 -0.32%
HANG SENG 25417.99
359.47 1.43%
NIKKEI 225 42984.31
404.04 0.95%
FTSE 100 9208.21
-8.66 -0.09%
NIFTY 24741.00
6.70 0.03%
×
Ask Your Question
close
refresh